Cargando…
Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol
BACKGROUND: Evidence for the role of the gut microbiome in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) is emerging. Strategies to manipulate the gut microbiota towards a healthier community structure are actively being investigated. Based on their ability to favorably modulate the...
Autores principales: | Lambert, Jennifer E., Parnell, Jill A., Eksteen, Bertus, Raman, Maitreyi, Bomhof, Marc R., Rioux, Kevin P., Madsen, Karen L., Reimer, Raylene A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669628/ https://www.ncbi.nlm.nih.gov/pubmed/26635079 http://dx.doi.org/10.1186/s12876-015-0400-5 |
Ejemplares similares
-
Gut microbiota and obesity: Impact of antibiotics and prebiotics and potential for musculoskeletal health
por: Klancic, Teja, et al.
Publicado: (2020) -
Evaluation of yellow pea fibre supplementation on weight loss and the gut microbiota: a randomized controlled trial
por: Lambert, Jennifer E, et al.
Publicado: (2014) -
Effect of prebiotic intake on gut microbiota, intestinal permeability and glycemic control in children with type 1 diabetes: study protocol for a randomized controlled trial
por: Ho, Josephine, et al.
Publicado: (2016) -
Prebiotic Mannan-Oligosaccharides and Their Role in the Gut Microbiota
por: Asbury, Rachel, et al.
Publicado: (2022) -
Effect of a prebiotic supplement on knee joint function, gut microbiota, and inflammation in adults with co-morbid obesity and knee osteoarthritis: study protocol for a randomized controlled trial
por: Fortuna, Rafael, et al.
Publicado: (2021)